Modulation of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment by Natural Products

被引:0
作者
Jhon Jairo Calderon
Karol Prieto
Paola Lasso
Susana Fiorentino
Alfonso Barreto
机构
[1] Pontificia Universidad Javeriana,Grupo de Inmunobiología y Biología Celular, Facultad de Ciencias
[2] Pontificia Universidad Javeriana,Departamento de Microbiología
来源
Archivum Immunologiae et Therapiae Experimentalis | 2023年 / 71卷
关键词
Myeloid-derived suppressor cells; MDSCs; Tumor microenvironment; Cancer; Natural products; Phytotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
During carcinogenesis, the microenvironment plays a fundamental role in tumor progression and resistance. This tumor microenvironment (TME) is characterized by being highly immunosuppressive in most cases, which makes it an important target for the development of new therapies. One of the most important groups of cells that orchestrate immunosuppression in TME is myeloid-derived suppressor cells (MDSCs), which have multiple mechanisms to suppress the immune response mediated by T lymphocytes and thus protect the tumor. In this review, we will discuss the importance of modulating MDSCs as a therapeutic target and how the use of natural products, due to their multiple mechanisms of action, can be a key alternative for modulating these cells and thus improve response to therapy in cancer patients.
引用
收藏
相关论文
共 448 条
  • [41] Khan Z(2019)Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression Br J Cancer 120 16-1944
  • [42] Noonan KA(2020)Myeloid cell-derived arginase in cancer immune response Front Immunol 11 938-751
  • [43] Cao Y(2019)More than just attractive: How CCL2 influences myeloid cell behavior beyond chemotaxis Front Immunol 10 2759-12345
  • [44] Trillo-Tinoco J(2021)Orchestration of myeloid-derived suppressor cells in the tumor microenvironment by ubiquitous cellular protein TCTP released by tumor cells Nat Immunol 22 947-4151
  • [45] Sierra RA(2009)Myeloid-derived suppressor cells down-regulate L-selectin expression on CD4+ and CD8+ T cells J Immunol 183 937-1791
  • [46] Chen J(2021)Landscape of myeloid-derived suppressor cell in tumor immunotherapy Biomark Res 9 77-1581
  • [47] Sun HW(2020)TIGIT as an emerging immune checkpoint Clin Exp Immunol 200 108-215
  • [48] Yang YY(2009)Oral administration of a soluble 1–3, 1–6 β-glucan during prophylactic survivin peptide vaccination diminishes growth of a B cell lymphoma in mice Int Immunopharmacol 9 1298-e737
  • [49] Cheng P(2017)Tadalafil has biologic activity in human melanoma. Results of a pilot trial with Tadalafil in patients with metastatic Melanoma (TaMe) Oncoimmunology. 6 e1326440-272
  • [50] Corzo CA(2018)The unfolded protein response and cell fate control Mol Cell 69 169-2312